Current and historical daily PE Ratio for Theseus Pharmaceuticals Inc (
) from 2021 to Apr 28 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Theseus Pharmaceuticals stock (THRX) PE ratio as of Apr 28 2024 is 0.
More Details
Theseus Pharmaceuticals Inc (THRX) PE Ratio (TTM) Chart
Theseus Pharmaceuticals Inc (THRX) PE Ratio (TTM) Historical Data
View and export this data going back to 2021. Start your Free Trial
Total 599
- 1
- 2
- 3
- 4
- 5
- 6
- 7
| Theseus Pharmaceuticals PE Ratio (TTM) Historical Data | |||
|---|---|---|---|
| Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
| 2024-04-28 | At Loss | 2023-12-19 | At Loss |
| 2024-02-23 | At Loss | 2023-12-18 | At Loss |
| 2024-02-22 | At Loss | 2023-12-15 | At Loss |
| 2024-02-21 | At Loss | 2023-12-14 | At Loss |
| 2024-02-20 | At Loss | 2023-12-13 | At Loss |
| 2024-02-16 | At Loss | 2023-12-12 | At Loss |
| 2024-02-15 | At Loss | 2023-12-11 | At Loss |
| 2024-02-14 | At Loss | 2023-12-08 | At Loss |
| 2024-02-13 | At Loss | 2023-12-07 | At Loss |
| 2024-02-12 | At Loss | 2023-12-06 | At Loss |
| 2024-02-09 | At Loss | 2023-12-05 | At Loss |
| 2024-02-08 | At Loss | 2023-12-04 | At Loss |
| 2024-02-07 | At Loss | 2023-12-01 | At Loss |
| 2024-02-06 | At Loss | 2023-11-30 | At Loss |
| 2024-02-05 | At Loss | 2023-11-29 | At Loss |
| 2024-02-02 | At Loss | 2023-11-28 | At Loss |
| 2024-02-01 | At Loss | 2023-11-27 | At Loss |
| 2024-01-31 | At Loss | 2023-11-24 | At Loss |
| 2024-01-30 | At Loss | 2023-11-22 | At Loss |
| 2024-01-29 | At Loss | 2023-11-21 | At Loss |
| 2024-01-26 | At Loss | 2023-11-20 | At Loss |
| 2024-01-25 | At Loss | 2023-11-17 | At Loss |
| 2024-01-24 | At Loss | 2023-11-16 | At Loss |
| 2024-01-23 | At Loss | 2023-11-15 | At Loss |
| 2024-01-22 | At Loss | 2023-11-14 | At Loss |
| 2024-01-19 | At Loss | 2023-11-13 | At Loss |
| 2024-01-18 | At Loss | 2023-11-10 | At Loss |
| 2024-01-17 | At Loss | 2023-11-09 | At Loss |
| 2024-01-16 | At Loss | 2023-11-08 | At Loss |
| 2024-01-12 | At Loss | 2023-11-07 | At Loss |
| 2024-01-11 | At Loss | 2023-11-06 | At Loss |
| 2024-01-10 | At Loss | 2023-11-03 | At Loss |
| 2024-01-09 | At Loss | 2023-11-02 | At Loss |
| 2024-01-08 | At Loss | 2023-11-01 | At Loss |
| 2024-01-05 | At Loss | 2023-10-31 | At Loss |
| 2024-01-04 | At Loss | 2023-10-30 | At Loss |
| 2024-01-03 | At Loss | 2023-10-27 | At Loss |
| 2024-01-02 | At Loss | 2023-10-26 | At Loss |
| 2023-12-29 | At Loss | 2023-10-25 | At Loss |
| 2023-12-28 | At Loss | 2023-10-24 | At Loss |
| 2023-12-27 | At Loss | 2023-10-23 | At Loss |
| 2023-12-26 | At Loss | 2023-10-20 | At Loss |
| 2023-12-22 | At Loss | 2023-10-19 | At Loss |
| 2023-12-21 | At Loss | 2023-10-18 | At Loss |
| 2023-12-20 | At Loss | 2023-10-17 | At Loss |
Theseus Pharmaceuticals Inc (THRX) PE Ratio (TTM) Comparison
| Company | Market Cap(Mil) | PE Ratio (TTM) |
|---|
Business Description
Business Description
Theseus Pharmaceuticals Inc
NAICS : 325412
SIC : 2834
ISIN : US88369M1018
Description
Theseus Pharmaceuticals Inc is a biopharmaceutical company focused on improving the lives of cancer patients through the discovery, development and commercialization of transformative targeted therapies. The company's development programs are designed to address drug resistance mutations in key driver oncogenes, which are mutated genes that cause cancer.
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers